145 related articles for article (PubMed ID: 22524657)
1. Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: unusually high frequency of down-regulation in breast cancer tissues.
Torigoe T; Asanuma H; Nakazawa E; Tamura Y; Hirohashi Y; Yamamoto E; Kanaseki T; Hasegawa T; Sato N
Pathol Int; 2012 May; 62(5):303-8. PubMed ID: 22524657
[TBL] [Abstract][Full Text] [Related]
2. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5.
Tsukahara T; Kawaguchi S; Torigoe T; Asanuma H; Nakazawa E; Shimozawa K; Nabeta Y; Kimura S; Kaya M; Nagoya S; Wada T; Yamashita T; Sato N
Cancer Sci; 2006 Dec; 97(12):1374-80. PubMed ID: 16995877
[TBL] [Abstract][Full Text] [Related]
4. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
5. Alterations of HLA class I and II antigen expression in preinvasive, invasive and metastatic cervical cancers.
Ryu KS; Lee YS; Kim BK; Park YG; Kim YW; Hur SY; Kim TE; Kim IK; Kim JW
Exp Mol Med; 2001 Sep; 33(3):136-44. PubMed ID: 11642549
[TBL] [Abstract][Full Text] [Related]
6. Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.
Temponi M; Kekish U; Hamby CV; Nielsen H; Marboe CC; Ferrone S
J Immunol Methods; 1993 May; 161(2):239-56. PubMed ID: 8505553
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
[TBL] [Abstract][Full Text] [Related]
8. Defective HLA Class I Expression and Patterns of Lymphocyte Infiltration in Chordoma Tumors.
Patel SS; Nota SP; Sabbatino F; Nielsen GP; Deshpande V; Wang X; Ferrone S; Schwab JH
Clin Orthop Relat Res; 2021 Jun; 479(6):1373-1382. PubMed ID: 33273248
[TBL] [Abstract][Full Text] [Related]
9. Differential HLA class I subunit (A, B, C heavy chain and β
Ugolini F; Szumera-Ciećkiewicz A; Baroni G; Nesi G; Mandalà M; Ferrone S; Massi D
Virchows Arch; 2023 Feb; 482(2):359-368. PubMed ID: 36437414
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.
Sasaki T; Ravindranath MH; Terasaki PI; Freitas MC; Kawakita S; Jucaud V
Int J Cancer; 2014 Apr; 134(7):1558-70. PubMed ID: 24105714
[TBL] [Abstract][Full Text] [Related]
11. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
Wintzer HO; Benzing M; von Kleist S
Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
[TBL] [Abstract][Full Text] [Related]
12. Expression of HLA class I antigen and proteasome subunits LMP-2 and LMP-10 in primary vs. metastatic breast carcinoma lesions.
Gobbi G; Mirandola P; Micheloni C; Solenghi E; Sponzilli I; Artico M; Soda G; Zanelli G; Pelusi G; Fiorini T; Cocco L; Vitale M
Int J Oncol; 2004 Dec; 25(6):1625-9. PubMed ID: 15547699
[TBL] [Abstract][Full Text] [Related]
13. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
14. The epitope recognized by pan-HLA class I-reactive monoclonal antibody W6/32 and its relationship to unusual stability of the HLA-B27/beta2-microglobulin complex.
Tran TM; Ivanyi P; Hilgert I; Brdicka T; Pla M; Breur B; Flieger M; Ivasková E; Horejsí V
Immunogenetics; 2001 Aug; 53(6):440-6. PubMed ID: 11685454
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients.
Tanaka K; Tsuchikawa T; Miyamoto M; Maki T; Ichinokawa M; Kubota KC; Shichinohe T; Hirano S; Ferrone S; Dosaka-Akita H; Matsuno Y; Kondo S
Int J Oncol; 2012 Apr; 40(4):965-74. PubMed ID: 22134332
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition.
Kitamura H; Torigoe T; Asanuma H; Honma I; Sato N; Tsukamoto T
J Urol; 2007 Aug; 178(2):692-6. PubMed ID: 17574613
[TBL] [Abstract][Full Text] [Related]
17. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of HLA class I expressing in gastric carcinoma defined by monoclonal anti-pan HLA class I antibody, EMR8-5.
Lee HW; Min SK; Ju YS; Sung J; Lim MS; Yang DH; Lee BH
J Gastrointest Surg; 2011 Aug; 15(8):1336-43. PubMed ID: 21512844
[TBL] [Abstract][Full Text] [Related]
19. Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.
Morabito A; Dozin B; Salvi S; Pasciucco G; Balbi G; Laurent S; Pastorino S; Carli F; Truini M; Bruzzi P; Del Mastro L; Pistillo MP
Hum Immunol; 2009 Jul; 70(7):492-5. PubMed ID: 19410618
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.
Feinmesser M; Sulkes A; Morgenstern S; Sulkes J; Stern S; Okon E
J Clin Pathol; 2000 Apr; 53(4):286-91. PubMed ID: 10823125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]